2001
DOI: 10.1016/s0165-2427(01)00347-6
|View full text |Cite
|
Sign up to set email alerts
|

The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
62
0
2

Year Published

2003
2003
2019
2019

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 59 publications
(64 citation statements)
references
References 9 publications
0
62
0
2
Order By: Relevance
“…2,5,10 Using 150 EAU as the positive-negative determinants, the overall interlaboratory concordance of results for grasses, trees, and weeds was 94.2%, 94.5%, and 93.0%, respectively. These results are consistent within and among laboratories as well as with previously defined observations.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…2,5,10 Using 150 EAU as the positive-negative determinants, the overall interlaboratory concordance of results for grasses, trees, and weeds was 94.2%, 94.5%, and 93.0%, respectively. These results are consistent within and among laboratories as well as with previously defined observations.…”
Section: Discussionmentioning
confidence: 97%
“…[3][4][5][10][11][12] The selection of allergens included in the allergen-specific therapeutic regimen relies on demonstration of immunoglobulin (Ig)E-mediated hypersensitivity by either intradermal skin testing or allergen-specific IgE serology. 1,2,6,10 Only recently has critical evaluation of some of the currently available tests been addressed. 7,8,13,14 In 2009, the performance characteristics of a monoclonal antibody cocktail-based enzyme-linked immunosorbent assay (macELISA) were described, and a preliminary interlaboratory evaluation between 2 laboratories that run this assay was provided.…”
Section: Introductionmentioning
confidence: 99%
“…90 Canine atopic dermatitis, which affects approximately 10% of all dogs, has an immunopathogenesis comparable to that of human atopic dermatitis. 62 Similar to their human atopic counterparts, who have high rates of secondary recurrent S. aureus and Malassezia spp.…”
Section: Antimicrobial Peptide Production In Atopic Dermatitismentioning
confidence: 99%
“…infections, 91 there are high rates of S. pseudintermedius and M. pachydermatis superinfections in canine atopic skin. 90 These cutaneous superinfections complicate management and further compromise the integrity of the skin barrier, and may be due in part to abnormally low AMP levels.…”
Section: Antimicrobial Peptide Production In Atopic Dermatitismentioning
confidence: 99%
“…Chaque cas est particulier et une thérapeutique combinée, associant traitements des complications, traitement symptomatique, éviction allergénique et immunothérapie spéci-fique, est la clé du succès (OLIVRY et SOUSA, 2001b).…”
Section: Autres Traitementsunclassified